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Abstract
To establish a simple and quantitative live cell fusion assay for placental syncytialization, we generated stable GFP and
dsRed expressing fusogenic BeWo cell lines. Fluorescent Activated Cell Sorting was shown to provide a quantitative
determination of forskolin (cAMP-mediated) fusion in a time and concentration dependent manner consistent with the
increased secretion of beta human chorionic gonadotrophin (b-HCG) and appearance of multi-nucleated cells. Analyses of
the fusion process demonstrated that in addition to increased cAMP levels, simultaneous reduction of intracellular calcium
and inhibition of Type 1 phosphatidylinositol 3 kinase (PI3K)/Akt signaling also resulted in cell fusion. Although individual
blockade of calcium channel function or PI3K/Akt signaling was without effect, the combination with forskolin resulted in a
potentiation of cell fusion. These data demonstrate syncytialization is a complex process that depends upon the regulation
of distinct signaling inputs that function in concert with each other.
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Introduction
Cellular fusion to form multi-nucleated structures is a highly
coordinated process that allows tissues to develop specific
properties and functions that are not possible in mononuclear
cells. For example, the fusion of myoblasts to form large multi-
nucleate syncytia is necessary for skeletal muscle development and
for these tissues to undergo regulated contraction for force
generation [1,2]. The formation and maintenance of the placental
syncytiotrophoblast structure through fusion of trophoblasts is
essential for separating fetal and maternal blood and is required
for successful embryonic implantation, subsequent oxygen/
nutrient transport and the secretion of specific placentally derived
hormones necessary for fetal development [3]. Following fertiliza-
tion and prior to blastocyst formation, trophoblasts undergoing
fusion form an early syncytiotrophoblast at the embryonic pole
and subsequent to implantation continues to fuse with mononu-
clear cytotrophoblasts to generate a barrier for maternal-fetal
exchange and for placental endocrine hormone secretion [4].
In general, cell-cell fusion initiates with recognition and
adhesion between two potentially fusing cells followed by fusogenic
pore formation, expansion and mixing of the cell surface bilayers
resulting in cytoplasmic continuity [5]. A variety of studies have
suggested the involvement of several proteins that are thought to
be involved in the fusion process. For example, syncytin 1 and 2
are primarily syncytiotrophoblast proteins thought to interact with
neutral amino acid receptors, ASCT1 or 2 that function as
syncytin receptors [6,7]. Evidence for a direct role of syncytin 1 in
trophoblast cell-cell fusion is supported by anti-sense oligonucle-
otide treatment of primary isolated cytotrophoblasts that results in
decreased cell fusion [8]. However using villus explants, syncytin 1
anti-sense oligonucleotides were also found to decrease the
number of cytotrophoblast opposite to that expected if cytotro-
phoblast fusion was inhibited [8]. CD98 is a cell surface antigen
that is expressed in cytotrophoblast and has been implicated in
virus-induced cell fusion and osteoclast formation [9]. Reduction
in CD98 expression by both anti-sense oligonucleotides and RNAi
was also observed to inhibit cell fusion [10]. Other studies have
reported a necessary role for the ADAM proteins particularly
ADAM12 [11] as well as exposure of phosphatidylserine to the
outer membrane leaflet have also been implicated [6,12].
In addition to the uncertainty of the fusogenic effectors and
mechanism of action, the molecular signaling pathways that
regulate trophoblast fusion have also not been extensively
investigated. Various studies have reported the requirement of
caspase 8 activation, microtubule associated protein stathmin,
transcription factor GCMa and reduction of protein tyrosine
phosphatase activity implicating increased tyrosine kinase activity
in the fusion process (reviewed in [6]). Despite these studies, a
detailed understanding of the specific regulatory events control
trophoblast fusion is critical as the integrity of the syncytiotropho-
blast depends upon continuous fusion with mononuclear cytotro-
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live cell-cell fusion assay using the human choriocarcinoma BeWo
cell line. This assay builds upon previous work utilizing flow
cytometry [14] and use of fluorescence to separate endomitosis
from fusion [15]. Using this assay system we now demonstrate that
cell fusion is controlled by the regulation of calcium influx and Akt
activity.
Results
Fusogenic characteristics of stable GFP and dsRFP
expressing BeWo cells
To develop an efficient and simple quantitative cell fusion assay,
we transfected fusogenic BeWo cells and control non-fusogenic
JEG-3 cells with both Green Fluorescent Protein (GFP) and Red
Fluorescent Protein (dsRed) and generated stable cell lines
(Fig. 1A). Mixing the BeWo-GFP and BeWo-dsRed together in
the presence of forskolin (Fig.1A, panels e, f, g, h), an established
activator of cAMP and inducer of BeWo cell fusion, resulted in the
formation of fused cells as visualized by the presence of multiple
nuclei in larger wheat germ agglutinin (WGA) labeled aggregated
cells (Fig.1A, panel h). In contrast, cAMP was ineffective in the
induction of JEG-3-GFP and JEG-3-dsRed cell fusion (Fig.1A,
panels a, b, c, d). Confirmation that GFP and dsRed BeWo cells
underwent functional membrane fusion similar to wild type BeWo
cells there was a marked induction (,1,000-fold) of b-HCG
secretion following forskolin treatment that was essentially
identical in wild type BeWo and the GFP/dsRed expressing
BeWo cells (Fig. 1B). Furthermore, neither BeWo nor the JEG-3
cells in the basal state or the JEG-3 cells in the presence of
forskolin displayed any significant levels of b-HCG secretion.
To establish a quantitative assay for BeWo cell fusion, we took
advantage of flow cytometry to distinguish between cells that are
single labeled with either GFP or dsRed versus those that are
double labeled with both GFP and dsRed. As shown in contour
plot in Figure 2, the majority of GFP-labeled BeWo cells in the
absence of forskolin were positive for GFP with very low levels in
the gated region of double positive fluorescent signal indicated by
the insert box on the right (Fig. 2A, Top). The inset box on the left
shows the fluorescent signals observed in control non-GFP/dsRed
expressing BeWo cells. Similarly, dsRed labeled BeWo cells were
only positive for Red fluorescence (Fig. 2B, Top). When the GFP-
labeled and dsRed labeled BeWo cells were combined only
0.027% of the cells were scored positive for both labels (Fig. 2C,
Top). Forskolin treatment of GFP labeled BeWo cells resulted in a
rightward shift of the GFP signal (Fig. 2D, Top) indicating
increased fluorescence per unit cell. Similarly, forskolin treatment
of dsRED labeled BeWo cells resulted in an upward dsRED signal
(Fig. 2E, Top) indicating increased fluorescence per unit cell.
However, when the GFP and dsRed labeled BeWo cells are mixed
and treated with forskolin, the individual shifts are observed along
with the formation of a new population of double positive cells that
increases to approximately 4.5% (Fig. 2F, Top). In contrast, GFP
and dsRED JEG-3 cells individually showed a limited shift in
fluorescence signal following forskolin treatment (Fig. 2A–C,
Bottom) and very few double positive cells when mixed in the
presence of the forskolin (Fig. 2D–F, Bottom). As a control, the
inset box on the left in Figure 2A, bottom shows the fluorescent
signals observed in non-GFP/dsRed expressing JEG-3 cells.
The forskolin-induced increase in individual GFP/dsRed
fluorescence signal and double positive signal of mixed GFP and
dsRed labeled BeWo cells could have resulted from either fusion of
mononuclear cells into multi-nucleated cells or due to aggregation
independent of fusion. To address this issue, we compared Side-
scatter width (SSC-W) versus Forward-scatter width (FSC-W) by
FACS analysis. The linear increase between untreated and
forskolin-stimulated double BeWo cells is consistent cell fusion
and not aggregation (Fig. 3A and B) [16]. Additional analysis of
Forward-scatter area (FSC-A) revealed that the increased
intensities seen in both dsRED and GFP BeWo cells treated with
forskolin represented fusion of these cell populations (Fig. 3C) since
their size was commensurate with those of the double positive cells,
as previously been reported [17]. Confocal microscopy confirmed
that the double positive BeWo cells were mainly composed of
fused cells characterized by a multinucleated syncytium (Fig. 3E).
In contrast, in absence of forskolin, the cell population contained
mono-nucleated individual cells that displayed no change in cell
size (Fig. 3D). In addition, quantitative-PCR (q-PCR) analysis
revealed that expression of fusion markers such as syncytin-1 and
b-HCG was increased in the sorted fused cells, consistent with the
fused BeWo cell population displaying normal syncytiotrophoblast
function (Fig. 3F and G).
Having established a quantitative fusion assay, we next
optimized syncytialization by examining the time and dose-
responsiveness of forskolin stimulation cell fusion. As shown in
Figure 4A, following 24 h of stimulation maximum fusion of
BeWo cells occurred at 50 mM forskolin. In contrast, the non-
fusogenic JEG-3 cells remained unresponsive and cellular fusion
was not significant even with 100 mM forskolin treatment. In
addition, syncytialization of the BeWo cells was readily detectable
as early as 12 h after forskolin treatment (50 mM) with maximum
fusion at 48 h (Fig. 4B). Therefore, having optimized conditions
for cell fusion, in all subsequent studies we stimulated BeWo cells
with 30 mM forskolin for 24 h since this was on the linear part of
the forskolin dose response and time course curves.
BeWo cell fusion is enhanced by LY294002 but
unaffected by wortmannin
The Type 1 phosphatidylinositol 3-kinase (PI3K) is a central
signaling node for many extracellular effectors that integrates a
variety of intracellular biological responses [18]. We therefore
initially examined the potential involvement of Type 1 PI3K-
dependent signals in the control of BeWo cell fusion. As typically
observed, in the absence of forskolin the reporter BeWo cells
displayed a relatively low level of fusion that was increased
approximately five-fold following forskolin treatment (Fig. 5A).
Treatment with the PI3K inhibitor LY294002 (LY) also resulted in
an equivalent increase in cell fusion and potentiated the extent of
fusion in the presence of forskolin. Surprisingly however, the PI3K
inhibitor wortmannin was completely without effect and was
unable to potentiate cell fusion induced by forskolin. Both LY and
wortmannin were able to inhibit phospho-Akt, which is down-
stream of PI3K, at the concentrations used (Fig. 5B). Since
LY294002 is a less specific PI3K inhibitor than wortmannin, these
data suggest that LY294002 was having an effect through another
pathway in conjunction with or independent of PI3K function.
Therefore, we next screened for other known targets of
LY294002 to regulate BeWo cell fusion. As shown in Figure 6A,
treatment of BeWo cells with inhibitors of the myosin-light chain
protein kinase, peptide 18 (MLCK), the DNA-dependent protein
kinase inhibitor NU1076 (NU), the broad inhibitor of the PI3K
family PI103, the inhibitor of creatine kinase-2 (4,5,6,7-tetra-
bromobenzotriazole; (TBB)), and the potassium channel inhibitor
tetraethylammonium (TEA) all had no effect on BeWo cell fusion,
whereas the calcium channel inhibitor Nifedipine appeared to
have small effect to increase cell fusion. However, in the presence
of wortmannin, to inhibit the Type 1 PI3K, the co-inhibition of
calcium channel function by nifedipine resulted in a substantial
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tested inhibitors may have small effects to reduce the forskolin
stimulation of BeWo cell fusion, importantly nifedipine (like
wortmannin alone) did not enhance forskolin-stimulated fusion
(Fig. 6C). However, the combination of nifedipine and wortman-
nin together increased the effects of forskolin on BeWo cell fusion,
reproducing the effects of the LY294002 inhibitor (Fig. 6D). These
data strongly suggest that the positive effects of the LY294002 on
BeWo fusion are a result of PI3K inhibition in combination with
the inhibition of the calcium channel activity. Additionally, both
pathways are necessary and function concurrently in the
syncytialization process, as wortmannin and nifedipine alone do
Figure 1. BeWo and JEG cells expressing dsRED and GFP are functionally unchanged. A) Fusogenic (BeWo) and non-fusogenic (JEG-3)
human choriocarcinoma cell lines stably expressing GFP and dsRED each, were co-incubated and stimulated with 100 mM forskolin for 24 h. The cells
were then fixed, labeled with wheat germ agglutinin (WGA) alexa. The cells were visualized by confocal fluorescence microscopy for GFP (panels b
and f), dsRed (panels a and e), WGA-Alexa (panels c and g) and the merged image (panels d and h). B) Control BeWo (black bars) and JEG-3 (grey bars)
cells as well as transfected cells were treated with vehicle or with 100 mM Forskolin for 24 hours. Incubation media were collected and b-HCG
released in the media was measured using an ELISA assay. Data are expressed in mean 6 s.e.m and are representative of 3 independent experiments.
Stimulation with Forskolin resulted in a significant increase of b-HCG in BeWo cells p,0.001. A smaller but still significant increase was exhibited by
JEG cells p,0.05. No significant difference in b-HCG release was noted between either the transfected BeWo or JEG as compared to their controls.
doi:10.1371/journal.pone.0029353.g001
Regulation of Trophoblast Cell-Cell Fusion
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29353not display any significant effects on forskolin-induced BeWo cell
fusion.
BeWo fusion requires both a decrease of intracellular
calcium concentration and Akt inhibition
If the calcium channel is involved in BeWo cell fusion, then
intracellular calcium levels should be changed during this process.
To address this issue, intracellular calcium levels during the
syncytialization process was determined using flow cytometry in
native BeWo cells labeled with the inverse calcium indicator fura
red (Fig. 7A). Addition of 8-Bromo-cAMP resulted in a marked
time-dependent decrease in intracellular calcium levels. Similarly,
LY294002 also elicited a decrease in intracellular calcium levels.
To examine the role of intracellular calcium influx regulating
BeWo cell fusion, we took advantage of thapsigargin, a
sesquiterpene lactone that raises cytosolic calcium concentration
by blocking the calcium pump of the endoplasmic reticulum [19].
Thapsigargin completely abrogated forskolin-induced fusion of the
Figure 2. Comparison of fusion measurement utilizing flow cytometry in GFP and dsRED expressing BeWo and JEG cells. Cells were
cultured with vehicle (panels A–C)o r3 0mM forskolin (panels D–E) for 24 h. The results are two-parameter plots GFP fluorescence (measured on the
GFP channel) or dsRED fluorescence (measured on the PE Cy-5 channel). Results were analyzed using FlowJo (8.8.6) software. Gating was performed
as described in Experimental Procedures and is indicated by the boxed region on the right of each panel. BeWo cells are shown on the top panels (A–
F) and JEG-3 cells on the bottom panels (A–F). Negative controls for BeWo (A, inset top left) and JEG-3 (A, inset bottom left) cells non-expressing GFP
or dsRed. The same gates were used throughout this study and each contour map represents the counting of 10,000 events.
doi:10.1371/journal.pone.0029353.g002
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syncytialization process is dependent on a decrease in intracellular
calcium concentration, consistent with the effects of nifedipine.
Since Akt is a major downstream target for the Type 1 PI3K
signaling pathway, we determined the role of Akt in concert with
calcium channel inhibition. Treatment with forskolin resulted in
the typical induction of BeWo cell fusion (Fig. 7C). Blockade of Akt
activation using the Akt1/2 inhibitor (Akt I) alone or in
combination with forskolin had no additional affect. As previously
observed, calcium channel inhibition (nifedipine) alone or in
combination with forskolin also had no additional effect. However,
both nifedipine and Akt inhibitor treatment mirrored the effect of
LY294002 effectively stimulating BeWo cell fusion and potentiat-
ing the fusion in the presence of forskolin. These data demonstrate
that maximum BeWo cell fusion is a complex process that requires
increased intracellular cAMP coupled with decreased intracellular
calcium levels and inhibition of PI3K/Akt signaling.
Discussion
The multi-nucleated syncytiotrophoblast provides the inter-
face that separates fetal and maternal blood and functions in the
transport of various nutrients, metabolic waste products and
synthesis of a variety of essential hormones [20]. The
Figure 3. Forskolin Induces BeWo cell fusion and not aggregation. Forward-scatter width (FSC-W) was plotted against Side-scatter width
(SSC-W) in unstimulated (A) and forskolin-stimulated (B) BeWo cells. Analysis of fused cells size compared to control cells (C). Control (orange) cells
are smaller than dsRED/dsRED fused BeWo cells (red), GFP/GFP fused BeWo Cells (green) and dsRED/GFP fused BeWo cells (blue) indicating the
increase in intensity is as a result of increased fusion. Representative confocal microscopic images of sorted unfused BeWo (D) and fused BeWo (E)
cells. BeWo cells were incubated with vehicle or 30 mM Forskolin for 24 h. The fused and non-fused cells were sorted by FACS, RNA was extracted the
expression of syncytin-1 (F) and ß-HCG (G) mRNA was quantified by quantitative RT-PCR. Relative quantitation was performed using cells treated or
not with forskolin in six well plates as control. Actual Ct values are displayed underneath. Data are expressed in mean 6 s.e.m and are representative
of 4 independent experiments.
doi:10.1371/journal.pone.0029353.g003
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with mononuclear cytotrophoblasts, as disruption of cytotropho-
blast fusion results in syncytiotrophoblast necrosis [21]. Under-
standing the complex cell biological and signaling processes
responsible for regulating cytotrophoblasts fusion has become an
emerging issue as alterations in this process are associated with
preeclampsia, a clinical condition associated with hypertension
and proteinuria that affects as many as 10% of all pregnancies
[22].
Currently, several groups have collectively identified a variety of
potential targets involved in the fusion process. However, we still
have a rudimentary knowledge of the physiologically relevant
fusion proteins, their mechanisms of action and signaling pathways
that control these processes. One barrier to advances in this field
Figure 4. Dose and Time Response of BeWo fusion. A) BeWo (circles) and JEG cells (squares) were incubated with the indicated concentrations
of forskolin for 24 h and the proportion of fused cells was analyzed by flow cytometry. B) BeWo cells were incubated with 30 mM forskolin for the
times indicated and the proportion of fused cells was determined by flow cytometry at the indicated time points. Data are expressed in mean 6 s.e.m
and are representative of 4 independent experiments.
doi:10.1371/journal.pone.0029353.g004
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cytotrophoblast fusion. To address this need, we have developed a
sensitive and highly reproducible system taking advantage of the
human chorinocarcinoma cell line BeWo, used as a representative
in vitro system for cytotrophoblast cell-cell fusion. By generating
stable GFP and dsRed BeWo cell lines, these reporter cells can be
mixed and, following standard stimulation via elevation of
intracellular cAMP fusion can be readily quantified using
fluorescent activated cell sorting. In this system, treatment with
forskolin induces a robust time and concentration increase in cell-
cell fusion from a low non-stimulated background. However, since
each cell whether mono or multi-nucleated is counted as one unit,
this assay actually underestimated the total extent of fusion. The
average number of nuclei per in vitro syncytium under these
conditions is 6 (data not shown), thus the average number of
nuclear fusion events following forskolin stimulation is in actuality
approximately 22%. In any case, these data demonstrate that the
fusion of the stable fluorescent protein-tagged BeWo cells provides
a very sensitive, efficient and reproducible cell-cell fusion assay
system. Moreover, the failure of the non-fusogenic cell line JEG-3
to display any significant double positivity reassured us that the
phenomena we were measuring represented cell fusion as opposed
Figure 5. Differential effects of LY294002 and wortmannin on fusion. BeWo cells (A) were incubated with 50 mM LY294002 (LY) or
wortmannin (10 mM) alone or with forskolin (30 mM) for 24 h and the proportion of fused cells was determined by flow cytometry analysis. LY294002
and wortmannin are effective inhibitors of PI3 kinase at the concentrations used (B). Total Akt and pS473-Akt was immunoblotted in BeWo cell
extracts from vehicle treated control, hypoxia-stimulated, 30 mM forskolin-stimulated, 50 mM LY, 10 mM wortmannin, hypoxia plus LY and hypoxia
plus wortmannin treated cells. This is a representative immunoblot independently performed 4 times.
doi:10.1371/journal.pone.0029353.g005
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it utilizes live cells permitting the downstream interrogation of
these cells using either hormonal assays or quantitative PCR.
Using this system we have uncovered an unexpected interplay
between intracellular calcium and the PI3K/Akt signaling
pathway that appears to function in parallel with the cAMP
pathway mediating cell fusion. Although forskolin elevation of
cAMP is an effective inducer of BeWo cell fusion, this was
completely blocked by increasing intracellular calcium levels.
Moreover, 8-Bromo-cAMP also resulted in a reduction in
intracellular calcium. The requirement for reduced intracellular
calcium in BeWo cell fusion is quite surprising as myoblast fusion
Figure 6. Dissection of LY294002 effects on fusion. BeWo cells were incubated for 24 h with different inhibitors (described in the manuscript)
alone (A) or in presence of 10 mM wortmannin (B) and proportion of fused cells was assessed by FACS analysis. Nifedipine (10 mM) significantly
increased fusion in the presence of 10 mM wortmannin (p,0.001). The effects of 30 mM forskolin was determined with the different inhibitors alone
(C) or in presence of 10 mM wortmannin (D) and proportion of fused cells was assessed by FACS analysis. Nifedipine significantly increased fusion
when 30 mM forskolin and 10 mM wortmannin were used together. (p,0.001). Data are expressed in mean 6 s.e.m and are representative of 3
independent experiments.
doi:10.1371/journal.pone.0029353.g006
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e29353Figure 7. The role of calcium in BeWo syncytialization. A) Fura red was used as an inverse intracellular calcium indicator and calcium transients
were measured in real time utilizing Flow Cytometry. Fura Red was measured with the perCP channel at 488 nm. The top panel shows the effects of
ionomycin 1 mM on the calcium transient with a decrease in intensity as intracellular calcium increases. The second panel shows the increase in fura red
as calcium levels are decreased by EGTA. In the third and fourth panels, real time decreases in intracellular calcium are seen with both addition of cAMP
(8-bromo-cAMP 1.5 mM - third panel) and LY294002 (50 mM - fourth panel). B) Effects of thapsigargin (100 nM) on BeWo fusion were determined by
incubating the BeWo cells with thapsigargin in the presence or absence of 30 mM forskolin for 24 h. Thapsigargin completely abolished the presence of
double positivity assessed by flow cytometry. C) Cells were incubated with vehicle (control, open bar) or with 30 mM forskolin for 24 hr (black bars). The
incubations were repeated in the presence of nifedipine (10 mM) or in the presence of nifedipine (10 mM) and Akt Inhibitor VIII (Akt I at 10 mM).
Nifedipine alone did not influence fusion, but nifedipine and Akt Inhibitor VIII increased fusion in both control and forskolin treated cells.
doi:10.1371/journal.pone.0029353.g007
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specific differences in these fusion mechanisms [23]. Although
inhibition of calcium influx appears to be functionally important in
BeWo cell fusion [24], it is not sufficient as nifedipine itself does
neither induce cell fusion nor potentiates forskolin-mediated
fusion.
In concert with calcium channel inhibition, inhibition of PI3K/
Akt signaling itself was also not sufficient to induce BeWo cell
fusion and also was unable to potentiate forskolin-stimulated
fusion. However, the combination of calcium channel inhibition
with PI3K/Akt inhibition was just as effective as forskolin in
stimulating BeWo cell fusion. Furthermore, calcium channel and
PI3K/Akt inhibition together potentiated forskolin-stimulated cell
fusion. Thus these finding underscore that multiple signaling
pathways can functional cooperate to drive syncytialization and
suggest these signals allow for precise regulation of placental
development in vivo based upon the maternal/fetal environment.
With this live cell assay system in-hand, further studies can now be
initiated to determine the upstream signals and downstream
targets that functionally mediate trophoblast cell-cell fusion.
Methods
Cells and culture conditions
Fusogenic BeWo cells and non-fusogenic JEG-3 cells were
obtained from ATCC (Manassas, VA, USA) and cultured in F-
12K (Invitrogen, Carlsbad, CA, USA) or Dulbecco’s Modified
Essential Medium (DMEM, Invitrogen, Carlsbad, CA) respective-
ly, both supplemented with 10% heat inactivated fetal bovine
serum (Invitrogen, Carlsbad, CA, USA) and 100 units/ml
penicillin, and 100 mg/ml of streptomycin (SigmaAldrich, St.
Louis, MO, USA).
Lentiviral packaging
pLVX-DsRed-Monomer (Clontech CA, USA) was packaged as
lentivirus in HEK-293 cells using lentivirus packaging mix
(SigmaAldrich, St. Louis, MO, USA) according to the manufac-
turer’s instructions. Briefly, HEK293T cells in DMEM, supple-
mented with 10% fetal bovine serum and 4 mM L-glutamine,
were grown to 70%–80% confluence in 100 mm dishes. On the
second day, 182 ml of OPTI-MEM serum free media and 16 mlo f
FUGENE 6 (Roche, IN, USA) transfection reagent were
combined with a transfection cocktail of 26 ml of lentiviral
transfection mix and 2.6 mg of pLVX-DsRed-Monomer and
added to the cells. The subsequent day, the cells were fed with
10 ml of DMEM and after 16 h this media was removed and
replaced with fresh media. The cells were incubated for a further
36 h when the media were collected and stored at 4uC. Media
were replaced and collected again 24 h later. After filtering the
collected medium through 0.45 mm filters, the virus was
concentrated by spinning at 4,000 g for 15 min followed by a
second spin (1,000 g for 2 min at room temperature). The
concentrated virus was stored at -80uC. The titer of lentiviral
vectors was determined by dilution. GFP lentiviral transduction
particles were purchased ready made from Sigma (SHC003 at
10
9 TU/ml).
Lentiviral Transduction
Lentiviral transduction of BeWo and JEG-3 cells was performed
according to the manufacturer’s protocol (SigmaAldrich, St. Louis,
MO, USA). Briefly, 1.6610
4 of BeWo and JEG-3 cells were added
to wells (in triplicate for GFP and dsRED) in a 96 well plate and
incubated for 20 h to achieve a confluency of 70%. The media
were removed and replaced with 110 ml Minimum Essential
Medium (MEM) supplemented with 10% Fetal calf serum and
hexadimethrine bromide (final concentration 8 mg/ml, SIGMA)
containing 5 ml of GFP virus or 12 ml of the dsRED virus. The
following day, the media containing virus were removed and
120 ml of fresh media were added. On day 3, the media was
removed and replaced with fresh media containing puromycin at
6 mg/ml. This was continued until colonies expressing GFP or
dsRED were identified. These were then expanded. dsRED virus
was calculated as 10
8 TU/ml. The MOI for GFP was 4 in both
BeWo and JEG-3, the MOI for dsRED was 8 in both cell types.
Beta-HCG quantification
Assessment of beta-HCG release by control and lentiviral
transduced BeWO and JEG-3 cells was assessed by addition of
50 mM forskolin (EMD Biosciences, Gibbstown, NJ, USA) for
24 h. The beta-HCG released in the media was determined using
an ELISA kit from R&D (Minneapolis, MN, USA) according to
the manufacturer’s instructions.
Flow cytometry
After the treatments, cells were trypsinized and suspended in
HBSS containing 2% Fetal calf serum and 0.2 mg/ml DNAse and
filtered through a 100 micron filter to minimize aggregation.
These cells were placed on ice and immediately processed by flow
cytometry.
Flow cytometry was performed on GFP and dsRed expressing
BeWo cell lines using BDFACSCORP ARIA equipped with Blue
(488 nm), Green (532 nm), Yellow (561 nm), Red (638 nm) and
Violet lasers (407 nm). The blue and the Yellow-green lasers were
used to excite GFP and dsRED, respectively. 548/20 nm band
pass filter was used for collecting GFP signals, and a 660/20 nm
band pass filter was used to collect dsRed signals. Gating strategy:
A total of 10 000 events were collected for analysis. Results were
analyzed using FlowJo (8.8.6) software. Briefly, Side-scatter height
(SSC-H) was plotted against Side-scatter width (SSC-W) to
exclude doublets and identify live cells; the cells were then
subjected to analysis with Forward-scatter height (FSC-H) against
Forward-scatter width (FSC-W) to ensure doublet exclusion.
Subsequently, GFP/dsREd single or double positive populations
were quantified. Analysis of double positive cells revealed a linear
increase in size compared to control cells confirming doublet
exclusion (Figure S1).
Western blotting
Cells were rinsed three times with PBS then lysed with ice-cold
lysis buffer [50 mM Tris-HCl (pH 7.5), 0.1% (vol/vol) Triton X-
100, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 10 mM sodium-
glycerophosphate, 5 mM sodium pyrophosphate, 1 mM sodium
vanadate, 0.1% (vol/vol) 2-mercaptoethanol, and protease inhib-
itors (1:1000 dilution of protease inhibitor cocktail; Sigma)]. Lysate
protein content was determined using the Bio-Rad Bradford
procedure. Proteins were resolved by SDS-PAGE, transferred to
PVDF membrane and subjected to immunoblotting with specific
antibodies (phospho-Akt & Total Akt (Cell Signaling, Danvers,
MA, USA). Proteins were visualized with the Odyssey Infrared
Imaging System (LI-COR Biosciences, Lincoln, NE, USA).
Induction of Akt phosphorylation, as a measure of Akt activation,
was accomplished by incubating the BeWo cells in hypoxic
conditions as previously described [25].
Intracellular calcium determination
BeWo cells were labeled with Fura Red AM (Invitrogen,
Carlsbad, CA, USA), an inverse fluorescent calcium probe which
Regulation of Trophoblast Cell-Cell Fusion
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incubating cells suspended in 1.5 ml buffer (HBSS containing 2%
Fetal calf serum and 0.2 mg/ml DNAse) with Fura Red AM at a
final concentration of 10 mM for 20 min at 37uC and washing the
cells with PBS prior to experiments. cAMP (8-bromo-cAMP
1.5 mM) and LY294002 (50 mM) were added immediately prior to
processing via flow cytometry. For calcium free experiments, cells
were suspended in buffer containing EGTA (10 mM). Ionomycin
3 mM was added just prior to FACS analysis for investigation of
raised intracellular calcium. Measurements of calcium transients
were performed using BDFACSCORP ARIA with excitation at
488 nm and emission at 590 nm.
Inhibitors
Nifedipine (Calcium channel inhibitor) was used at a final
concentration of 10 mM and tetraethylammonium chloride
(potassium channel inhibitor) was used at a final concentration
of 5 mM (both SigmaAldrich, St. Louis, MO, USA). NU7026
(DNA dependent protein kinase inhibitor) was used at a final
concentration 0.3 mM, TBB (4,5,6,7-Tetrabromobenzotriazole, a
casein kinase 2 inhibitor) at a final concentration of 10 mM, PI103
(3-[4-(4-Morpholinylpyrido[39,29:4,5]furo[3,2-d]pyrimidin-2-yl]-
phenol hydrochloride, an inhibitor of mTOR and p110alpha)
was used at a final concentration of 1 mM,M L C KP e p t i d e1 8
(Myosin Light Chain Kinase Inhibitor Peptide 18) was used at a
final concentration of 1 mM (all from Tocris Ellisville, MO,
USA). Akt Inhibitor VIII, Isozyme-Selective was used at a final
concentration of 10 mM (EMD Chemicals Gibbstown, NJ,
USA). The selection of inhibitor concentrations used was based
on manufacturer’s data and comparable published studies.
Confocal Microscopy
Fused and non-fused cells were sorted and collected by flow
cytometry and placed on Lab-Tek chamber slides (Nalge Nunc
International, Rochester, NY). The slides were fixed and cell
membranes were stained with wheatgerm agglutinin conjugated to
Alexa Fluor 594 (SigmaAldrich, St. Louis, MO, USA) whilst nuclei
were stained using ProLong antifade with DAPI (Invitrogen,
Carlsbad, CA, USA). Slides were visualized by confocal fluores-
cence microscopy using a TCS SP5 laser scanning confocal
microscope (Leica microsystems, Buffalo Grove, IL, USA).
Quantitative PCR analysis
Fused or non-fused cells were collected either from cell sorting
or from wells (as controls), immediately placed into QIAzol Lysis
Reagent (Quiagen, Valencia, CA, USA) according to the
manufacturer’s protocol. Total RNA was isolated using RNeasyH
Mini Kit (Qiagen Sciences, Maryland, USA) and then reverse-
transcribed to cDNA using the SuperScript VILO cDNA synthesis
kit (Invitrogen, Carlsbad, CA, USA). TaqMan (Applied Biosys-
tems, Branchburg, NJ, USA) RT-PCR was performed for
measurement of mRNA for fusion markers beta-HCG and
syncytin. Relative expression levels of the mRNAs were deter-
mined using standard curves. Samples were adjusted for total
mRNA content by comparison with GAPDH expression. All
primer-probe mixtures were from Applied Biosystems (Branch-
burg, NJ, USA).
Statistics
Results are expressed as mean 6 standard error of the mean
(s.e.m). Differences between incubation conditions were tested for
statistical significance (p,0.05) using Student’s unpaired t-test. All
experimental treatments were performed in biological triplicate
with each biological replicate having technical triplicates.
Supporting Information
Figure S1 Forskolin-stimulated BeWo cell fusion and
not aggregation. A) GFP and dsRed labeled BeWo cells were
mixed, treated with 30 mM forskolin for 24 h and analyzed for
Side-scatter Height (SSC-H) versus Side-scatter width (SSC-W) as
an assessment aggregation. B) This population was then analyzed
for Forward-scatter Height (FSC-H) versus Forward-scatter width
(FSC-W) to confirm the absence of aggregation. C) The BeWo
cells were then assessed using PE-Cy5 (for dsRED) and GFP (for
GFP). The non-fused (D) and fused (E) cells were assessed for size
using Forward-Scatter Area (FSC-A) versus Side-scatter Area
(SSC-A) revealing that they were smaller than the fused cells and
were not aggregated as revealed by their linear increase.
(TIF)
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